Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 19, 2012
Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable